The Calwell Practice, PLLC and Calwell Luce diTrapano, PLLC v. James F. Humphreys & Associates, L.C.

CourtIntermediate Court of Appeals of West Virginia
DecidedMay 23, 2024
Docket23-ica-220
StatusPublished

This text of The Calwell Practice, PLLC and Calwell Luce diTrapano, PLLC v. James F. Humphreys & Associates, L.C. (The Calwell Practice, PLLC and Calwell Luce diTrapano, PLLC v. James F. Humphreys & Associates, L.C.) is published on Counsel Stack Legal Research, covering Intermediate Court of Appeals of West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Calwell Practice, PLLC and Calwell Luce diTrapano, PLLC v. James F. Humphreys & Associates, L.C., (W. Va. Ct. App. 2024).

Opinion

IN THE INTERMEDIATE COURT OF APPEALS OF WEST VIRGINIA FILED THE CALWELL PRACTICE, PLLC and May 23, 2024 CALWELL LUCE DITRAPANO, PLLC, ASHLEY N. DEEM, DEPUTY CLERK INTERMEDIATE COURT OF APPEALS Defendants Below, Petitioners OF WEST VIRGINIA

v.) No. 23-ICA-220 (Cir. Ct. Putnam Cnty. Case No. CC-40-2004-C-465)

JAMES F. HUMPHREYS & ASSOCIATES, L.C., Plaintiff Below, Respondent

MEMORANDUM DECISION

Petitioners The Calwell Practice, PLLC and Calwell Luce diTrapano, PLLC (collectively “Calwell”) appeal the May 2, 2023, order of the Circuit Court of Putnam County. In that order, the circuit court granted summary judgment in favor of Respondent James F. Humphreys & Associates, L.C. (“Humphreys”) and against Calwell regarding a dispute over a fee sharing agreement between the parties. Humphreys filed a response.1 Calwell filed a reply.

This Court has jurisdiction over this appeal pursuant to West Virginia Code § 51- 11-4 (2022). After considering the parties’ arguments, the record on appeal, and the applicable law, this Court finds that there is no error in the circuit court’s order and no substantial question of law. For these reasons, a memorandum decision affirming the circuit court’s order is appropriate under Rule 21 of the Rules of Appellate Procedure.

This matter concerns a fee sharing agreement between the parties. Beginning in 2004, the Monsanto Company (“Monsanto”) was the subject of approximately fifty-five civil suits in West Virginia alleging toxic exposure from its plant in Nitro, West Virginia. At the inception of the Monsanto litigation, the parties herein served as co-counsel and their work and fee sharing arrangement was memorialized by a Memorandum of Understanding that involved equal sharing of both costs and potential attorneys’ fees that would be awarded.

In January of 2012, the parties agreed to terminate Humphreys’ involvement in the Monsanto litigation. To that end, the parties entered into a fee sharing agreement whereby Humphreys agreed to withdraw from the litigation in exchange for Calwell’s agreement

1 Calwell is represented by R. Booth Goodwin II, Esq., Benjamin B. Ware, Esq., Stephanie H. Daly, Esq., and L. Dante’ diTrapano, Esq. Humphreys is represented by J. Zak Ritchie, Esq., Michael B. Hissam, Esq., and Andrew C. Robey, Esq. 1 that in the event of a settlement or favorable verdict, Humphreys would receive 12.5% of any settlement or verdict up to $110,000,000.00. The fee sharing agreement states, in relevant part:

In addition to the Expenditure Reimbursement Amount described herein, solely in the event of a settlement or a favorable verdict, JH shall further be entitled to receive a negotiated share of Attorney’s fees (“Attorney’s fees”) of 12.5% of Attorney’s fees calculated as a percentage of any settlement or verdict up to $110,000,000.00. By way of example, if the case is awarded a judgment or is settled for $110,000,000.00 or less, JH shall be entitled to receive an amount equal to 12.5% of any attorney’s fees awarded.

In February of 2012, the Monsanto litigation settled. The terms of settlement were memorialized in two separate agreements: the Property Class Settlement Agreement and the Medical Monitoring Class Settlement Agreement, both of which were approved by the circuit court in January of 2013. Under those agreements, Monsanto agreed to pay up to $84,000,000.00 for medical monitoring claims and $9,000,000.00 for property cleanup. In consideration of this settlement, the circuit court awarded Calwell attorneys’ fees and expenses in the amount of $20,000,000.00. As required by the fee sharing agreement, Calwell paid Humphreys the 12.5% negotiated share of this initial fee award.

The then-presiding judge of the circuit court, the Honorable Derek C. Swope, also approved a potential additional $9,500,000.00 for future attorneys’ fees, the receipt of which was contingent upon the satisfaction of certain milestones. These future fee awards would be paid out of an interest-bearing escrow account (referred to as the “Contingent Attorney’s Fees Fund”), which was funded exclusively by Monsanto. From that fund, Calwell would receive $200.00 in attorneys’ fees for each class member to register and qualify for property cleanup. Calwell would also receive $500.00 in attorneys’ fees for each class member to register and qualify for medical monitoring. These periodic awards were commonly referred to as “periodic incentive awards.” Again, in recognition of the fee sharing agreement, Calwell paid Humphreys the 12.5% negotiated share of these periodic incentive awards.

The Medical Monitoring Class Settlement Agreement also contained a “triggering event,” which was tantamount to a final incentive award. If one hundred class members registered to participate in serum dioxin screening and 25% of those participants presented with defined levels of dioxin in their system, then additional benefits would be provided to the class. And, in consideration of those additional benefits, Calwell would be awarded the remaining $6,500,000.00 from the Contingent Attorney’s Fees Fund when and if the triggering event occurred.

On June 23, 2014, Humphreys filed a charging lien against the settlement fund. This lien was eventually the subject of a June 2014 hearing in circuit court. Following the

2 hearing, the circuit court entered what the parties refer to as the “2014 Order.” That order states, in relevant part:

The Court FINDS and ORDERS that Mr. Calwell and Mr. Humphreys have agreed that Mr. Humphreys shall receive twelve (12) and a half percent from the attorney’s fees Mr. Calwell receives as Class Counsel in both the property and medical monitoring class settlements. The Court further ORDERS that Mr. Humphreys receive twelve (12) and half percent of any incentive payments Mr. Calwell receives for the number of Class Members who register for medical monitoring or property clean-up benefits. Once a level of five hundred (500) participants are registered, the Court will release the incentive fee payments to Mr. Calwell in the amounts of Five Hundred Dollars ($500) for each medical monitoring participants and Two Hundred Dollars ($200) for each property remediation participants. These fees will be released at each interval of 500 persons registered and at the end of the Registration Period. Finally, the Court ORDERS that Mr. Humphreys receive twelve (12) and a half percent of any attorney’s fee payments that Mr. Calwell receives based upon the occurrence of the triggering event. Mr. Calwell must also reimburse Mr. Humphreys for his costs.

At some point thereafter, it became evident that the “triggering event” would not occur. The serum dioxin screening was unlikely to yield the necessary results to satisfy the triggering event. Calwell then questioned the reliability of those screening results. As a result, Monsanto and Calwell agreed to amend the Medical Monitoring Class Settlement Agreement, resulting in the Modified Medical Monitoring Class Settlement Agreement. In that modified agreement, Monsanto and Calwell agreed that, despite the non-occurrence of the “triggering event,” the class would nonetheless be afforded additional screening and Calwell would instead be awarded $3,000,000.00 (rather than $6,500,000.00) from the Contingent Attorney’s Fees Fund.

Relevant to Calwell’s arguments on appeal, prior to the circuit court’s approval of the modified agreement, Humphreys filed for Chapter 11 bankruptcy. See In re James F. Humphreys & Assocs., L.C., 554 B.R. 355 (Bankr. S.D. W. Va. 2016). In February of 2016, Humphreys filed its Schedule of Assets and Liabilities and Statement of Financial Affairs. There, Humphreys disclosed “referral/joint representation agreements” as one of the various classes of assets available for administration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Painter v. Peavy
451 S.E.2d 755 (West Virginia Supreme Court, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
The Calwell Practice, PLLC and Calwell Luce diTrapano, PLLC v. James F. Humphreys & Associates, L.C., Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-calwell-practice-pllc-and-calwell-luce-ditrapano-pllc-v-james-f-wvactapp-2024.